Best Researcher Award

Jyoti Batra, Gladstone Institutes, United States

Jyoti Batra
Affiliation	Gladstone Institutes
Country	United States
Scopus ID	56661930400
Documents	21
Citations	6,072
h-index	16
Subject Area	Molecular Virology, Proteomics, Functional Genomics
Event	Global Sensor Awards
ORCID	0000-0002-2335-0607

Jyoti Batra is a molecular virologist and proteomics researcher recognized for contributions to the understanding of virus–host interaction networks, immune evasion mechanisms, and cross-species viral transmission. Her research integrates systems-level molecular sensing approaches with advanced proteomic technologies to investigate emerging RNA viruses, including Ebola virus, influenza virus, and SARS-CoV-2. Her work has contributed to the identification of host restriction factors, therapeutic targets, and molecular determinants associated with zoonotic risk and viral pathogenesis.[1]

Abstract

Jyoti Batra’s research portfolio focuses on molecular virology, systems biology, and host–pathogen interactions. Her studies employ affinity purification mass spectrometry, interaction mapping, CRISPR-based methodologies, and functional genomics to characterize how viruses manipulate host cellular systems. Her work has contributed to understanding immune evasion, viral replication, mitochondrial targeting, and cross-species adaptation in major viral pathogens. Publications in journals such as Cell, Nature, Science, EMBO Journal, and Cell Host & Microbe demonstrate the translational and scientific relevance of her contributions.[2]

Keywords

• Molecular Virology
• Virus–Host Interactions
• Proteomics
• Functional Genomics
• SARS-CoV-2
• Ebola Virus
• Influenza Virus
• Immune Evasion
• Cross-Species Transmission
• Systems Biology

Introduction

The study of virus–host interactions has become increasingly important in understanding the emergence of infectious diseases and pandemic preparedness. Jyoti Batra has contributed extensively to this field through interdisciplinary research integrating virology, molecular biology, and systems-level proteomics. Her investigations into host restriction factors and viral immune evasion mechanisms have expanded current knowledge regarding zoonotic transmission and viral adaptation in mammalian hosts.[3]

Her research career includes appointments at Gladstone Institutes and Georgia State University, where she participated in collaborative international studies involving emerging viral pathogens. These studies have influenced ongoing research in antiviral drug development, host-targeted therapeutic strategies, and viral systems biology.[4]

Research Profile

Jyoti Batra serves as a Staff Research Scientist at Gladstone Institutes in San Francisco, California. Her expertise includes proteomics-based molecular sensing, interaction network analysis, molecular cloning, RNA sequencing, CRISPR technologies, viral infection assays, and computational analysis platforms such as Cytoscape and MaxQuant.[5]

She completed doctoral training in molecular virology through Monash University Malaysia and the International Centre for Genetic Engineering and Biotechnology in India. Earlier academic training in biochemistry was completed at the University of Delhi. Her educational and research trajectory reflects sustained engagement with infectious disease biology and molecular mechanisms of viral replication.[6]

Research Contributions

Batra’s research has significantly contributed to understanding how viruses interact with host proteins and cellular pathways. Her investigations into Ebola virus replication identified host regulators such as RBBP6 and uncovered non-canonical protein interactions associated with viral RNA synthesis and immune modulation.[1]

Her collaborative work during the COVID-19 pandemic contributed to landmark proteomic and phosphoproteomic studies that mapped SARS-CoV-2 interactions with host cellular machinery. These studies identified host proteins associated with viral replication and provided insight into potential therapeutic targets and antiviral intervention strategies.[3]

A notable recent contribution involved comparative coronavirus interaction mapping in bat and human cells, revealing network rewiring mechanisms associated with immune evasion and zoonotic potential. The work identified amino acid substitutions functioning as molecular switches that altered mitochondrial targeting and host interaction profiles across species.[1]

• Development of cross-species interactome mapping platforms.
• Identification of host restriction factors in bat cells.
• Discovery of host proteins regulating Ebola virus infection.
• Proteomic analyses of SARS-CoV-2 infection pathways.
• Research on influenza virus nuclear import and apoptosis pathways.

Publications

Jyoti Batra has authored and co-authored numerous peer-reviewed publications in internationally recognized scientific journals. Several publications have been associated with high-impact discoveries in virology, systems biology, and host-pathogen interaction mapping.[5]

1. Batra J. et al. Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential. Cell Host & Microbe, 2026.
2. Batra J. et al. Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection. EMBO Journal, 2021.
3. Bouhaddou M. et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell, 2020.
4. Gordon D.E. et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science, 2020.
5. White K.M. et al. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science, 2021.

Research Impact

The scientific contributions of Jyoti Batra have influenced contemporary research on emerging infectious diseases and host-targeted antiviral strategies. Her collaborative studies have been widely referenced within the scientific community and have contributed to advancing systems-level approaches in virology research.[1]

Her work on coronavirus interaction networks and proteomics has provided foundational datasets for understanding viral immune evasion and therapeutic targeting. These contributions have supported multidisciplinary collaborations across virology, structural biology, computational biology, and translational medicine.[2]

Award Suitability

Jyoti Batra’s research achievements demonstrate suitability for recognition in the fields of molecular virology, proteomics, and infectious disease biology. Her interdisciplinary investigations have contributed to the scientific understanding of viral evolution, host adaptation, and immune regulation. The breadth of her publication record, participation in high-impact international collaborations, and contributions to emerging virus research collectively support her recognition within academic and scientific award frameworks.[3]

• Extensive expertise in virus–host interaction biology.
• High-impact publications in internationally recognized journals.
• Contributions to pandemic-related virology research.
• Leadership in interdisciplinary scientific collaborations.
• Advanced methodological contributions in proteomics and genomics.

Conclusion

Jyoti Batra has established a research profile characterized by interdisciplinary innovation, methodological rigor, and impactful contributions to molecular virology. Her work has advanced scientific understanding of host–virus interactions across several major viral pathogens and has contributed to the broader field of infectious disease research. Through collaborative and translational research initiatives, she continues to contribute to the development of systems-level approaches for studying viral pathogenesis and immune evasion.[4]

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• Google Scholar Profile

References

1. Elsevier. (n.d.). Scopus author details: Jyoti Batra, Author ID 56661930400. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=56661930400
   
2. Batra J. et al. (2026). Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential. Cell Host & Microbe.
   https://doi.org/10.1016/j.chom.2026.04.015
   
3. Batra J. et al. (2021). Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection. EMBO Journal.
4. Gordon D.E. et al. (2020). Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science.
5. Gladstone Institutes. (n.d.). Research activities and institutional profile.
   https://www.gladstone.org/
   

Innovative Research Award

Mònica Mir – Institute for Bioengineering of Catalonia (IBEC), Biomedical Research Center in Bioengineering (CIBER-bbn), and University of Barcelona, Spain

Mònica Mir
Affiliation	IBEC, CIBER-bbn, University of Barcelona
Country	Spain
Scopus ID	12647442200
Documents	60
Citations	2,256
h-index	22
Subject Area	Biomedical Engineering, Biosensors, Organ-on-a-Chip
Event	Global Sensor Awards
ORCID	0000-0002-1490-8373

Mònica Mir is a Spanish biomedical engineer and researcher recognized for her contributions to biosensors, microfluidic systems, point-of-care diagnostics, and organ-on-a-chip technologies. Her interdisciplinary research integrates bioengineering, nanotechnology, and translational medicine to improve disease diagnostics and develop advanced in vitro disease models for neurological and neurodegenerative disorders.[1] She has contributed extensively to blood-brain barrier-on-a-chip systems, electrochemical biosensors, and neurovascular modeling platforms designed for personalized medicine and pharmaceutical evaluation.[2]

Abstract

This academic article presents the scientific profile and research accomplishments of Dr. Mònica Mir, a senior researcher specializing in biomedical engineering and biosensor technologies. Her work focuses on translational bioengineering approaches for disease diagnosis, monitoring, and advanced in vitro modeling systems. Dr. Mir has contributed significantly to the development of electrochemical biosensors, blood-brain barrier-on-a-chip systems, neurovascular models, and implantable sensing devices. Her collaborative and interdisciplinary research has supported advances in personalized medicine, neurodegenerative disease studies, and point-of-care technologies.[3]

Keywords

Biomedical Engineering; Biosensors; Organ-on-a-Chip; Blood-Brain Barrier; Microfluidics; Electrochemical Sensors; Point-of-Care Systems; Neuroengineering; Nanobiotechnology; Translational Medicine; Alzheimer’s Disease; Personalized Medicine

Introduction

The integration of bioengineering and nanotechnology has transformed modern healthcare research by enabling sophisticated diagnostic and therapeutic platforms. Among the leading contributors in this field is Dr. Mònica Mir, whose research addresses the need for reliable biosensing systems and physiologically relevant disease models.[4] Her scientific contributions are particularly relevant to neurological diseases, blood-brain barrier functionality, and organ-on-a-chip technologies designed to emulate complex biological environments.[5]

Dr. Mir’s academic journey includes training in analytical chemistry, chemical engineering, biotechnology, and biosensor technologies at institutions including the Universitat Rovira i Virgili, the University of Bath, and the Max Planck Institute. Her multidisciplinary expertise has enabled her to bridge engineering methodologies with biomedical applications.[1]

Research Profile

Dr. Mir currently serves as a Consolidated Senior Researcher at the Biomedical Research Center in Bioengineering (CIBER-bbn) and as Assistant Professor at the University of Barcelona. Her research profile reflects more than two decades of experience in translational bioengineering and biosensor development.[1]

Her scientific activities encompass biosensors, microfluidics, neurovascular modeling, implantable electrochemical devices, and organ-on-a-chip systems. She has coordinated European Union and national research projects focused on personalized medicine, blood-brain barrier models, and neurodegenerative disease monitoring platforms.[5]

• Principal Investigator of the EIC Pathfinder Challenge project “IV-Lab” focused on implantable smart sensing systems.
• Lead investigator of the eBRAIN project involving hippocampal blood-brain barrier-on-a-chip technologies.
• Scientific Coordinator for collaborative industrial projects involving HPV diagnostic point-of-care systems.
• Mentor and supervisor for doctoral, master’s, and postdoctoral researchers in biomedical engineering.

Research Contributions

One of Dr. Mir’s notable contributions is the development of advanced blood-brain barrier-on-a-chip models integrated with microelectrodes and electrochemical sensing systems. These platforms provide realistic physiological environments for evaluating nanoparticle permeability, neurovascular interactions, and therapeutic responses associated with neurodegenerative diseases such as Alzheimer’s disease.[3]

Her research has also explored implantable electrochemical microsensors for monitoring oxygen and pH levels in fetal ischemia and hypoxia studies. These technologies demonstrate potential clinical utility in prenatal diagnostics and real-time physiological monitoring.[4]

Dr. Mir has contributed to biosensor integration within organ-on-a-chip systems, enabling improved monitoring of biological responses and enhanced analytical performance for translational medicine applications.[5]

• Development of neurovascular unit-on-a-chip technologies.
• Electrochemical immunosensors for Alzheimer’s disease biomarker detection.
• Microfluidic biosensing systems for cancer liquid biopsy applications.
• Implantable multiparametric microsensors for physiological monitoring.

Publications

Dr. Mir has authored more than 59 peer-reviewed scientific publications, including articles in high-impact journals such as ACS Sensors, Journal of Nanobiotechnology, Materials Today Bio, and Biosensors & Bioelectronics.

1. Arellano, A. et al. (2025). Attenuation of blood-brain barrier dysfunction by functionalized gold nanoparticles against amyloid-β peptide in an Alzheimer’s disease-on-a-chip model. Materials Today Bio.
2. Palma-Florez, S. et al. (2024). Neurovascular unit on a chip: The relevance and maturity as an advanced in vitro model. Neural Regeneration Research.
3. Mir, M. et al. (2022). Biosensors Integration in Blood−Brain Barrier-on-a-Chip. ACS Sensors.
4. Marrugo-Ramírez, J. et al. (2021). Kynurenic Acid Electrochemical Immunosensor: Blood-Based Diagnosis of Alzheimer’s Disease. Biosensors.
5. Rivas, L. et al. (2020). Micro-needle implantable electrochemical oxygen sensor: ex-vivo and in-vivo studies. Biosensors & Bioelectronics.

Research Impact

Dr. Mir’s research has achieved measurable academic and translational impact through scientific publications, patent development, industrial collaborations, and interdisciplinary project leadership.[3] Her work has contributed to the advancement of personalized medicine and neuroengineering by improving experimental disease modeling systems and biosensor technologies.

Her scientific output includes over 2180 citations and an h-index of 21 according to Scopus metrics. She has served as editor and reviewer for several international journals and funding agencies, including the Swiss National Science Foundation, DBT India Alliance, and Agence Nationale de la Recherche.[1]

In addition to academic contributions, Dr. Mir co-founded the spin-off company NewCo S.L., highlighting the translational and entrepreneurial dimensions of her research activities.[2]

Award Suitability

Dr. Mònica Mir demonstrates strong suitability for recognition in biomedical engineering and biosensor innovation due to her sustained contributions to translational healthcare technologies. Her interdisciplinary expertise in organ-on-a-chip systems, electrochemical biosensors, and neuroengineering aligns with contemporary priorities in personalized medicine and biomedical diagnostics.[9]

Her leadership in European and national research initiatives, mentorship activities, editorial responsibilities, and technology transfer initiatives further support her profile as a distinguished researcher contributing to both scientific advancement and societal healthcare applications.[4]

Conclusion

Dr. Mònica Mir has established a significant research career in biomedical engineering, biosensors, and organ-on-a-chip technologies. Her scientific achievements reflect interdisciplinary innovation, translational healthcare applications, and collaborative research leadership. Through her contributions to biosensing systems, neurovascular disease models, and implantable diagnostic technologies, she continues to advance the field of biomedical engineering and translational medicine.[5]

External Links

• ORCID Profile
  
• Scopus Author Profile

References

1. Elsevier. (n.d.). Scopus author details: Mònica Mir, Author ID 12647442200. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=12647442200
   
2. Mir, M. et al. (2022). Biosensors Integration in Blood−Brain Barrier-on-a-Chip. ACS Sensors.
   https://doi.org/10.1021/acssensors.2c00123
   
3. Palma-Florez, S. et al. (2024). Neurovascular unit on a chip: The relevance and maturity as an advanced in vitro model. Neural Regeneration Research.
4. Marrugo-Ramírez, J. et al. (2021). Kynurenic Acid Electrochemical Immunosensor: Blood-Based Diagnosis of Alzheimer’s Disease. Biosensors.
5. Palma-Florez, S. et al. (2023). BBB-on-a-chip with integrated micro-TEER for permeability evaluation. Journal of Nanobiotechnology.